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Abstract
Complete consensus nucleotide sequences were determined for human metapneumovirus (HMPV) isolates CAN97-83 and CAN98-75,
representing the two proposed genotypes or genetic subgroups of HMPV. The overall level of genome nucleotide sequence identity and
aggregate proteome amino acid sequence identity between the two HMPV subgroups were 80 and 90%, respectively, similar to the
respective values of 81 and 88% between the two antigenic subgroups of human respiratory syncytial virus (HRSV). The diversity between
HMPV subgroups was greatest for the SH and G proteins (59 and 37% identity, respectively), which were even more divergent than their
HRSV counterparts (72 and 55% cross-subgroup identity, respectively). It is reasonable to anticipate that the two genetic subgroups of
HMPV represent antigenic subgroups approximately comparable to those of HRSV.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
Human metapneumovirus (HMPV) was first recovered
in 2001 in the Netherlands from infants and children expe-
riencing acute respiratory tract disease (van den Hoogen et
al., 2001). HMPV has been classified presumptively in the
Metapneumovirus genus, Pneumovirus subfamily, Para-
myxovirus family of the Order Mononegavirales, the non-
segmented negative-strand RNA viruses or mononegavi-
ruses. HMPV has since been isolated in several continents,
suggesting that it is worldwide in prevalence, and resembles
human respiratory syncytial virus (HRSV) with regard to
disease signs and the ability to infect and cause disease in
the young infant as well as individuals of all ages (Boivin et
al., 2002; Peret et al., 2002; Falsey et al., 2003; Osterhaus
and Fouchier, 2003). HRSV is the type species of the
Pneumovirus genus, the other genus of the Pneumovirus
subfamily (Collins et al., 2001). The prevalence, overall
impact on human health, age association, antigenic diver-
sity, and other aspects of HMPV epidemiology and biology
remain to be characterized more completely.
HMPV is an enveloped virus with a genome that is a
single negative strand of RNA of approximately 13 kb. A
nucleotide sequence was determined for most of the genome
of the prototype isolate 00–1 (Genbank Accession No.
AF371337) (van den Hoogen et al., 2002), although the
ends of the genome were not mapped or sequenced. This
analysis showed that, similar to the avian metapneumovi-
ruses (AMPV), the 3 to 5 HMPV gene order is N-P-M-
F-M2-SH-G-L. The mRNA encoded by the M2 gene con-
tains two overlapping open reading frames (ORFs) M2-1
and M2-2 that have the potential to encode separate pro-
teins, as has been confirmed for HRSV (Collins et al., 1990,
1996; Bermingham and Collins, 1999; Jin et al., 2000). By
analogy to AMPV and HRSV, the HMPV proteins are as
follows: N, nucleocapsid RNA binding protein; P, nucleo-
capsid phosphoprotein; M, nonglycosylated matrix protein;
F, fusion glycoprotein; M2-1, transcription elongation fac-
tor; M2-2, RNA synthesis regulatory factor; SH, small hy-
drophobic surface protein; G, major attachment protein; L,
* Corresponding author. Building 50, Room 6507, 50 South Dr. MSC
8007, Bethesda, MD 20892-8007. Fax: 1-301-496-8312.
E-mail address: ubuchholz@niaid.nih.gov (U.J. Buchholz).
R
Available online at www.sciencedirect.com
Virology 315 (2003) 1–9 www.elsevier.com/locate/yviro
0042-6822/$ – see front matter © 2003 Elsevier Inc. All rights reserved.
doi:10.1016/S0042-6822(03)00528-2
major polymerase subunit. These predicted HMPV proteins
have not yet been identified or characterized biochemically
and their functions have not yet been confirmed.
Comparison of sequences available for several HMPV
genes or gene fragments showed that the available HMPV
isolates can be grouped into two broad genotypes or sub-
groups (van den Hoogen et al., 2001; Peret et al., 2002;
Bastien et al., 2003), perhaps analogous to the two antigenic
subgroups A and B of HRSV (Anderson et al., 1985; Muf-
son et al., 1985; Johnson et al., 1987a,b; Johnson and Col-
lins, 1988a,b, 1989). In the present study we (i) determined
the first complete sequence for an HMPV genome and (ii)
compared complete genome sequences for isolates repre-
senting the two proposed genetic subgroups of HMPV. This
analysis supports the idea that these two genetic clusters are
subgroups that are approximately comparable in cross-sub-
group sequence divergence to the antigenic subgroups of
HRSV.
Results and discussion
Comparison of complete consensus genome sequences
HMPV isolates CAN97-83 and CAN98-75 (Boivin et al.,
2002; Peret et al., 2002) were propagated in vitro in LLC-
MK2 cells and virion RNA was isolated and subjected to
reverse transcription (RT)-PCR. The cDNA products were
analyzed by nucleotide sequencing performed directly on
the uncloned material to determine consensus sequences.
Primers designed from the published sequence for isolate
00-1 usually did not successfully prime on either CAN
isolate, presumably due to sequence divergence. We there-
fore designed primers to take advantage of putative con-
served gene-start and gene-end signals flanking the viral
genes. This provided initial sequence data from which ad-
ditional primers specific to either CAN isolate were de-
signed. The CAN97-83 isolate provided an unambiguous
sequence for its entirety, whereas the CAN98-75 isolate
yielded a sequence in which a number of positions in the SH
and G genes contained a mixture of two assignments. This
suggested that the isolate was a mixture of two or more
viruses that likely reflected quasispecies variants, either
present in the original clinical sample or arising during in
vitro passage. Analysis of cloned RT-PCR products span-
ning the SH and G genes produced two closely related sets
of sequences that likely represented at least two different
viruses. To obtain a sequence that could unambiguously be
attributed to a single replication-competent CAN98-75 vi-
rus, the isolate was subjected to biological cloning by
plaque isolation. Eight independent plaque-purified prepa-
rations yielded identical consensus sequences in the region
of SH and G that were consistent with that of one of the two
groups of cloned cDNA sequences. This sequence appears
to represent the major constituent and was taken to be
CAN98-75.
The 3 and 5 ends of the CAN97-83 and CAN98-75
genomes were mapped and sequenced by RT-PCR-based
rapid amplification procedures (see Materials and methods)
and the uncloned products were analyzed by nucleotide
sequencing, yielding unambiguous sequences. In addition,
the CAN97-83 genome was circularized with RNA ligase
and the region containing the joined ends was amplified by
RT-PCR. The resulting product was sequenced directly and
also was cloned, and 20 individual clones were sequenced.
These results were in complete agreement with those of the
rapid amplification protocols. The sequences of the 3 leader
region and the downstream end of the 5 trailer region of the
two CAN isolates are shown in Fig. 1A, revealing a very
high degree of relatedness between the two and a somewhat
lower degree of relatedness with AMPV and HRSV.
The genomes of isolates CAN97-83 and CAN98-75 were
13,335 and 13,280 nucleotides in length, respectively
(GenBank Accession No. AY297749 and AY297748, re-
spectively). Their gene maps are shown in Fig. 1B. Overall,
the two genomes shared 80% nucleotide identity, compared
to 81% between the A2 and B1 strains of HRSV represent-
ing the two HRSV antigenic subgroups A and B, respec-
tively (GenBank Accession No. M74568 and AF013254,
respectively). Similarly, the nucleotide sequence of
CAN98-75 was 80% identical to that of isolate 00-1 (ex-
cluding the regions for which sequence was unavailable for
00-1), representing a second cross-subgroup comparison.
The sequences of CAN97-83 and 00-1, representing an
intra-subgroup comparison, were 92% identical.
For most genera of the Paramyxovirus family, there is a
“rule of six,” whereby the nucleotide length of each genome
is an even multiple of six (Kolakofsky et al., 1998). In many
cases, the placement of cis-acting signals relative to hex-
amer spacing also follows a conserved pattern. However,
HMPV replication and gene expression do not appear to be
ruled by a phasing requirement based on the following
observations: (i) the sequences for the three available iso-
lates differ in length (CAN97-83, 13,335 nucleotides;
CAN98-75, 13,280 nucleotides; and 00-1, 13,378 nucleo-
tides, which was calculated assuming that the 00-1 termini
correspond in length to the others); (ii) no integer from 2 to
9 was evenly divisible into each of the three genomes; and
(iii) there was no apparent pattern of phasing for the gene
boundaries within or between isolates.
The genome of a mononegavirus, and presumably that of
HMPV, is transcribed beginning at its 3 end by a linear,
sequential, stop-restart process. Transcription is guided by
short gene-start and gene-end signals that flank each gene
and direct transcription initiation and termination/polyade-
nylation, respectively (Lamb and Kolakofsky, 2001). Fig. 2
shows putative gene-start, gene-end, and intergenic se-
quences of HMPV. The downstream end of each HMPV
gene is delineated by the putative 12- to 15-nucleotide
gene-end motif (consensus: AGTTAnnnAAAAA). This
motif is the same as that of HRSV (consensus: AGT-
TAnnnAAAAA) (Collins et al., 2001), consisting of (in
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positive sense) a highly conserved AGTTA pentamer, fol-
lowed by a poorly conserved A/T-rich trinucleotide, fol-
lowed by a tract of four to seven A residues. A sequence that
resembles the gene-end motif also is present near the down-
stream end of the HMPV leader region (Fig. 2), but further
work will be needed to determine whether this functions
similar to a gene-end signal.
The upstream end of each HMPV gene is delineated by
the 16-nucleotide gene-start motif (consensus: GGGA-
CAAnTnnnAATG; Fig. 2). The first 10 nucleotides of this
motif have some resemblance to the 10-nucleotide gene-
start signal of HRSV (consensus: GGGGCAAAT[A/T])
(Collins et al., 2001). One unusual feature of the gene-start
signal of all HMPV isolates sequenced to date is the pres-
ence of ATG at positions 14–16 (Fig. 2), which initiates the
major ORF. In the SH gene of CAN98-75 and 00-1, there is
an additional upstream ATG at gene-start positions 8–10;
however, this start site is unlikely to be used because of its
unfavorable sequence context. Further work will be needed
to determine whether the ATG at positions 14–16 is a
functional element of the HMPV gene-start signal or
whether the conserved spacing of this translational start site
plays some other role in gene expression.
The organization of the HMPV genome is compact.
Except for the internal M2-2 ORF, each ORF initiated at nt
14 of its mRNA, and in four (CAN97-83) or five (CAN98-
75) of the eight mRNAs, the ORF terminated within the
gene-end signal. Thus, noncoding gene regions are short.
Taking strain CAN98-75 as an example, 93.8% of the
genome was involved in ORFs, and 96.7% of the genome
was represented in the predicted array of monocistronic
mRNAs.
Sequence relatedness of ORFs and proteins between
subgroups
Table 1 shows the nucleotide sequence relatedness of the
various HMPV ORFs between the two putative genetic
subgroups (CAN97-83 versus CAN98-75) and within a sub-
group (CAN97-83 versus 00-1). Between the subgroups, the
HMPV ORFS shared 81–87% nucleotide identity except for
Fig. 1. Structure of the HMPV genome. (A) Alignment of the sequences (genome-sense) of the leader region (A) or the downstream end of the trailer region
(B) of HMPV CAN97-83 and CAN98-75 with the partial sequence of HMPV 00-1 and the sequences for avian metapneumovirus (AMPV) (Randhawa et
al., 1997) and HRSV strain A2. Shading denotes identity among at least three sequences. (B) Gene maps of HMPV isolates CAN97-83 and CAN98-75.
Individual genes are indicated by boxes, with gene lengths and boundaries within the complete genomic sequence given in nucleotides together with the
unmodified amino acid length (italics) of the deduced protein (in the case of M2, two predicted proteins, M2-1 and M2-2). The nucleotides lengths of the
extragenic 3 leader, 5 trailer, and intergenic regions are underlined.
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SH and G, which were substantially more divergent (69
and 59% identity, respectively). This pattern resembled
that of the two subgroups of HRSV, for which the per-
centage of nucleotide identity for the various ORFs was
81– 85% identical except for the more divergent M2-2,
SH, and G ORFs (69, 77, and 67% identity, respectively;
Table 1). For comparison, the HMPV intergenic regions
and the noncoding gene regions (exclusive of gene-start
and gene-end signals) were 48 and 54% identical, respec-
tively, between subgroups, compared to values of 42 and
approximately 50%, respectively, for HRSV (Johnson
and Collins, 1988b). Thus, the coding sequence for
HMPV G was only marginally more conserved than were
HMPV noncoding gene sequences in general (59 versus
54%). Extensive nucleotide sequence divergence for SH
and, in particular, G also was observed between two
Fig. 2. Predicted gene boundaries, cis-acting gene-start and gene-end signals, and intergenic regions of CAN97-83 (83) and CAN98-75 (75), shown as
positive-sense sequence. The top alignment shows the leader/N gene boundary, specifically the last 20–21 nucleotides of the leader region followed by the
first 21 nucleotides of the N gene. The second alignment shows the N/P gene boundary, specifically, the last 18 nucleotides of the N gene, followed by the
adjoining intergenic region, followed by the first 21 nucleotides of the P gene. Subsequent alignments show the P/M, M/F, F/M2, M2/SH, SH/G, G/L, and
L/trailer boundaries. Conserved sequence motifs at the end (gene-end) and beginning (gene-start) of each gene are indicated in bold upper case, and a
consensus is given below. Positions within these conserved motifs are numbered. Translational stop and start codons are underlined. Intergenic sequences
are shown: in the case of the longer intergenic regions, only the first five nucleotides on the upstream and downstream ends are shown, and the number of
nucleotides not shown is indicated. For each assignment in the consensus sequence, no more than two of the sequence pairs (CAN97-83/CAN98-75) could
have a heterologous assignment in both subgroup sequences.
Table 1
Percentage of amino acid or nucleotide sequence identity between the indicated strains of HMPV or HRSV for the indicated proteins and ORFsa
Viruses compared Percent amino acid sequence identity for indicated protein (percent nucleotide sequence identity for indicated ORF)
N P M F M2-1 M2-2 SH G L
CAN97-83 vs CAN 98-75 96 (84) 85 (81) 97 (85) 95 (84) 96 (85) 89 (87) 59 (69) 37 (59) 94 (84)
CAN97-83 vs 00-1 99 (94) 95 (92) 99 (94) 98 (94) 98 (94) 96 (95) 85 (88) 70 (77) 99 (95)
HRSV A2 vs HRSV B1 95 (85) 90 (85) 91 (85) 89 (81) 91 (84) 61 (69) 72 (77) 55 (67) 92 (85)
a Amino acid sequence identities were calculated based on the complete predicted proteins; in the case of G and SH, overhangs on the carboxy-terminal
side of alignments due to length differences were not included in the calculations. Nucleotide sequence identities for the corresponding ORFs are shown in
parentheses and are based on the protein-coding sequence exclusive of flanking noncoding sequence. For comparison, the HMPV intergenic regions were
48% identical between subgroups and noncoding gene sequences exclusive of conserved transcription signals were 54% identical, compared to values of 42%
and approximately 50% for HRSV (Johnson and Collins, 1988b).
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strains of the same subgroup (CAN97-83 versus 00-1,
Table 1).
Table 1 also shows the amino acid sequence relatedness
of the various HMPV proteins between the two subgroups
(CAN97-83 versus CAN98-75), and within a subgroup
(CAN97-83 versus 00-1). With regard to the total proteome,
the HMPV subgroups shared 90% amino acid sequence
identity, compared to 88% identity between the HRSV
subgroups. With regard to individual proteins, the most
conserved HMPV proteins were N, M, F, M2-1, and L
(94% identity between subgroups), followed by P and
M2-2 (85–89%), followed by the divergent SH (59%) and
G (37%) proteins. SH and G are the only ones for which the
percentage of relatedness at the amino acid level was less
than at the nucleotide level, suggesting that amino acid
substitutions were preferentially retained. While this article
was in preparation, Bastien et al. (2003) reported sequences
for the N, P, M, and F genes of 15 HMPV isolates: their
results for these four genes and proteins are similar to those
shown in Table 1.
The pattern of HMPV sequence diversity between sub-
groups has general similarities to that of HRSV (Table 1).
For HRSV, the “internal” virion proteins and the F protein
constituted a group of highly conserved species, while the
M2-2, SH, and G proteins were more divergent. The three
following differences between HMPV and HRSV will be
described in greater detail below: (i) the HMPV M2-2
protein was markedly more conserved (89% amino acid
identity between subgroups) than its HRSV counterpart
(61%); (ii) the HMPV F protein also was more conserved
than was the case for HRSV (95% identity between sub-
groups versus 89%); and (iii) the HMPV SH and G proteins
were markedly more divergent than their HRSV counter-
parts (59 and 37% identity between subgroups, respectively,
compared to 72 and 55%, respectively). Table 1 also com-
pares the HMPV proteins within a subgroup (CAN97-83
versus 00-1). For most of the proteins, the percentage of
amino acid identity was very high (95%), with the SH and
G proteins being more divergent (85 and 70% identity,
respectively). The value of 70% sequence identity for G
within an HMPV subgroup is much lower that the value of
91% reported for HRSV G from the analysis of seven
subgroup B strains (Sullender et al., 1991). Thus, the
HMPV SH protein and, in particular, the G protein were
markedly more divergent within and between subgroups
than was the case for their HRSV counterparts.
It was surprising to find that the HMPV M2-2 ORF and
protein exhibited a high level of identity between the two
putative subgroups, since M2-2 of HRSV is poorly con-
served (Table 1). In the case of HRSV, the M2-2 protein
was identified as a functional gene product by the observa-
tion that disruption of its ORF in infectious recombinant
virus resulted in altered virus growth and RNA synthesis
(Bermingham and Collins, 1999; Jin et al., 2000). The
HRSV M2-2 ORF is expressed by a ribosomal stop-restart
mechanism, whereby ribosomes that exit the M2-1 ORF
apparently double back and initiate translation at the over-
lapping M2-2 ORF (Ahmadian et al., 2000). For the HMPV
M2-2 ORF, there are two possible methionyl translational
start sites located 38 and 50 nucleotides upstream of the
translational termination codon of the M2-1 ORF. These
two sites are exactly conserved among all three strains
compared here and are embedded in highly conserved se-
quence.
As noted by van den Hoogen et al. (2002), the HMPV F,
SH, and G proteins appear to correspond to the three HRSV
surface glycoproteins F, SH, and G, although there was
clear sequence relatedness between HMPV and HRSV
counterparts only for F (33% amino acid identity). For
HRSV, G, and F are the only significant neutralization
antigens and are the major protective antigens (Collins et
al., 2001), whereas experiments in rodents suggested that
the HRSV SH protein is not a significant protective antigen
(Connors et al., 1991). The neutralization and protective
antigens of HMPV remain to be described. The HRSV F
protein has a high degree of antigenic relatedness between
subgroups (Johnson et al., 1987a), consistent with its se-
quence relatedness (Table 1), and is the major contributor to
HRSV cross-subgroup neutralization and protection. For
HMPV F, amino acid sequence identity between subgroups
was even higher than for HRSV, and it is reasonable to
anticipate that this similarly will make a substantial contri-
bution to cross-neutralization and cross-protection between
the HMPV subgroups. Conversely, the high degree of di-
vergence of the G protein between and within HMPV sub-
groups likely will compromise its contribution to cross-
neutralization and cross-protection to an even greater degree
than is the case for HRSV (Johnson et al., 1987a). Detailed
descriptions of the sequence of the HMPV F protein have
recently been published (van den Hoogen et al., 2002;
Bastien et al., 2003).
The HMPV SH protein, similar to its HRSV counterpart,
is predicted to be a type II glycoprotein that is inserted in the
plasma membrane by a hydrophobic signal/anchor sequence
located near its amino-terminus (Fig. 3A, boxed sequence),
with a cytoplasmic amino-terminus and an extracellular
carboxy-terminus. The SH proteins of isolates CAN98-75,
CAN97-83, and 00-1 varied in length (177, 179, and 183
amino acids, respectively; Fig. 3A) and were considerably
longer than their 64- or 65-amino-acid counterparts in
HRSV. The predicted extracellular domain has two to four
motifs for N-linked glycosylation, one of which is con-
served in all three isolates, as well as three or four potential
sites for O-glycosylation (Hansen et al., 1998) that are
clustered within residues 75–81 in all three isolates (Fig.
3A). In addition, the SH proteins of the three isolates con-
tain 9 or 10 cysteine residues, which are mostly in the
extracellular domain, 9 of which are conserved among all
three strains. The differences in length and amino acid
sequence between the SH proteins of the different isolates
were concentrated in the extracellular domain.
The HMPV G protein (Fig. 3B) also is a type II surface
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protein, bearing a general resemblance (but no significant
sequence relatedness) to the G protein of HRSV. The amino
acid lengths of the G proteins of isolates CAN98-75;
CAN97-83, and 00-1 were 236, 219, and 236, considerably
shorter than their 289- to 299-amino-acid counterparts in
HRSV. The HMPV G protein, similar to its HRSV coun-
terpart, contains a high percentage of serine plus threonine
residues (32–35% for the three isolates, compared to a data
base average of 13%) and a somewhat elevated level of
proline residues (7–8.5%, compared to an average of 5%).
CAN97-83, CAN98-75, and 00-1 had one, four, and four,
respectively, potential acceptor sites for N-linked glycosyl-
ation in the ectodomain. Each HMPV G protein contained
more than 40 predicted potential (Hansen et al., 1998)
acceptor sites for O-linked carbohydrate (not shown): by
analogy to HRSV it is likely that not all of these are used,
and usage might be heterogeneous. The serine, threonine,
proline residues, and the predicted sites for O-linked sugars
were concentrated in the predicted extracellular domain,
suggesting that this region has a long, extended, heavily
glycosylated “mucin-like” structure, as is thought to be the
case for RSV.
Fig. 3. Alignment of the amino acid sequences of the (A) SH and (B) G proteins of HMPV strains CAN98-75, CAN97-83, and 00-1. This includes comparison
between (CAN98-75 versus CAN97-83) and within (CAN97-83 versus 00-1) the proposed HMPV genetic subgroups. For strains CAN98-75 and 00-1,
assignments that differ from that of CAN97-83 are shown; dashes indicate gaps introduced to maximize the alignment or to denote the absence of
corresponding amino acids. Stars underneath each alignment denote amino acid identity among all three sequences; small dots indicate amino acid similarity
among all three. Proposed signal/transmembrane domains are boxed. Motifs for N-linked carbohydrate are underlined (N-X-T/S, where X is not proline). In
A, cysteine residues conserved among all three SH proteins are indicated with large dots, and potential sites for O linked glycosylation (Hansen et al., 1998)
of the SH proteins are as follows: CAN97-83, 75, 77, 78, 81; CAN98-75, 78, 79, 81, 00-1, 77, 78, 81.
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The HMPV G protein also resembles that of HRSV in
having most of the amino acid divergence localized to the
extracellular domain (Fig. 3B). Specifically, the cytoplas-
mic and transmembrane domains combined were 64 and
96% identical between and within subgroups, respectively,
compared to the remarkably low values for the extracellular
domain of 25 and 61% identity between and within sub-
groups. For comparison, the value of 25% amino acid se-
quence identity is comparable to that observed for the at-
tachment hemagglutinin-neuraminidase protein of
parainfluenza viruses from different genera, such as genus
Paramyxovirus versus genus Rubulavirus or Avulavirus,
and is substantially lower than the value of 42–66% identity
observed for the influenza A hemagglutinin glycoprotein
between subtypes H1, H2, and H3.
The HMPV G protein lacks several of the prominent
features of its HRSV counterpart. HMPV G lacks the con-
served 13-amino-acid domain in the HRSV G extracellular
domain that is exactly conserved among all HRSV strains
and is partially conserved in bovine RSV (Johnson et al.,
1987b; Teng and Collins, 2002). Indeed, the HMPV G
ectodomain did not contain more than three adjacent amino
acids conserved among all three isolates. HMPV G also
lacks the four conserved, closely spaced cysteine residues in
HRSV G that partially overlap the 13-amino-acid conserved
domain, form a cystine noose, and include a CX3C chemo-
kine motif (Tripp et al., 2001). The three HMPV G proteins
in Fig. 3B each contained only one or two cysteine residues,
with the only conserved one being at the inner face of the
cytoplasmic domain, representing a potential acceptor site
for fatty acid acylation. HMPV G also lacks a counterpart to
the second methionyl translational start codon in the HRSV
G ORF, which gives rise to a secreted form and is conserved
between HRSV subgroups (Roberts et al., 1994). Only iso-
late CAN98-75 has an appropriately located potential coun-
terpart (methionine-43), and it is the fourth rather than the
second methionyl residue.
For HRSV G, a high percentage of the nucleotide sub-
stitutions in the extracellular domain were shown to result in
amino acid coding changes, suggestive of a selective pres-
sure for amino acid change that is thought to be due to host
immunity (Johnson and Collins, 1989; Sullender et al.,
1991). Here, we extended this analysis to the extracellular
domains of the HMPV F, SH, and G proteins (data are
shown only for F and G in Table 2), based on alignments
between the two putative subgroups (isolates CAN97-83
versus CAN98-75). In each coding sequence alignment,
those codons having nucleotide differences were grouped
according to whether one, two, or three nucleotides were
involved: this was done because we particularly wanted to
focus the comparison on codons having a single nucleotide
difference, since this would directly demonstrate the likeli-
hood of an amino acid change per single nucleotide change.
Remarkably, 75% of the single nucleotide substitutions in
the G ectodomain were found to be associated with amino
acid substitutions (Table 2), compared to the value of 50%
for SH (not shown) and the low value of 6.8% for F, the last
being comparable to that observed for internal protein genes
(Johnson and Collins, 1989). This pattern also was observed
for the codons with two nucleotide changes (Table 2). Re-
peating an argument that we previously made for HRSV
(Johnson et al., 1987b; Johnson and Collins, 1988a), we
suggest that the extraordinary frequency of amino acid sub-
stitution per nucleotide substitution in HMPV G (and to a
lesser extent SH) reflects two factors: (i) selective pressure
for amino acid change, which might come from host im-
munity; and (ii) the ability of the protein to tolerate substi-
tution, which might be due to its proposed extended, un-
folded nature. In contrast, HMPV F appears to resemble
HRSV F, which is one of the more highly conserved pro-
teins despite its status as a major HRSV neutralization and
protective antigen. This likely reflects functional and struc-
tural constraints on amino acid substitution in this folded,
globular glycoprotein. The time scale of nucleotide and
amino acid substitution for HMPV is not known, but we
note that, for HRSV, it is difficult to detect antigenic drift
and thus the differences probably reflect a slow accumula-
tion over years.
In conclusion, complete genome sequences were deter-
mined for two HMPV isolates representing the two pro-
posed HMPV genetic subgroups. This completed the se-
quencing of the HMPV genome. Comparison of the
Table 2
Nucleotide substitutions in the coding sequence for the G or F extracellular protein domain and their effect on amino acid codinga
No. of nucleotide
changes per
codon
G coding sequence: No. of codons with
indicated effect on amino acid coding
(% of total codons)
F coding sequence: No. of codons with
indicated effect on amino acid coding
(% of total codons)
No change Substitution No change Substitution
1 15 (25%) 45 (75%b) 165 (93.2%) 12 (6.8%c)
2 1 (2%) 50 (98%) 8 (62%) 5 (38%)
3 1 (4%) 23 (96%) — 1
a Sequence alignments between CAN97-83 and CAN98-75 for the coding sequences for the extracellular domains of G or F (exclusive of signal,
transmembrane, and cytoplasmic sequences) were inspected and codons containing nucleotide substitutions were grouped according to the number of
substitutions. Each group was then sub-divided on the basis of whether the nucleotide substitution(s) resulted in an amino acid substitution.
b The value for HRSV G was 58% (Johnson and Collins, 1989).
c The value for HRSV F was 15% (Johnson and Collins, 1989).
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nucleotide and predicted amino acid sequences showed that
the divergence between these two subgroups is comparable
overall to that of the two HRSV antigenic subgroups.
Among the three surface proteins, the HMPV F protein was
highly conserved, even more so than for HRSV, while the
SH and G proteins were highly divergent, even more so than
for HRSV.
Material and methods
Cells and viruses
LLC-MK2 (ATCC CCL 7.1) cells were maintained in
OptiMEM I (Invitrogen GIBCO) supplemented with 5%
fetal bovine serum. HMPV CAN97-83 and CAN98-75 are
clinical isolates (Boivin et al., 2002; Peret et al., 2002) and
were propagated in our laboratory at 32°C in the presence of
5 g/ml trypsin.
RNA isolation
Virion-associated RNA was isolated directly from clar-
ified medium supernatants using the QIAamp viral RNA
purification kit (Qiagen) according to the manufacturer’s
instructions. Alternatively, virus was purified from the su-
pernatants by centrifugation on a 30 to 60% w/v sucrose
step gradient for 90 min at 26,000 rpm in an SW28 rotor.
The virus-containing fraction was diluted in TEN [10 mM
Tris–HCl (pH 7.4), 0.1 M NaCl, 1 mM EDTA] and virus
particles were pelleted by centrifugation at 25,000 rpm in an
SW28 rotor for 90 min. The virus pellet was resuspended in
500 l of TEN and RNA was isolated using the RNeasy kit
(Qiagen) according to the manufacturer’s instructions.
RT-PCR and nucleotide sequencing
Virion RNA was mixed with 50 pmol of each different
primer and incubated for 5 min at 70°C and 25 min at 60°C.
Reverse transcription with Superscript II enzyme (Invitro-
gen) was performed at 44°C for 1 h and at 51°C for 30 min.
PCR was performed with Platinum Pfx DNA polymerase
(Invitrogen). Nucleotide sequences of cDNA products were
determined by direct sequence analysis of the RT-PCR
products using an ABI 3100 sequencer with the Big-Dye
terminator ready reaction kit v1.1 (Applied Biosystems).
To map and sequence the 3 end of the HMPV genome,
virion RNA was converted into cDNA and amplified using
the 3 RACE System for Rapid Amplification of cDNA
Ends (Invitrogen) as specified by the manufacturer. Briefly,
vRNA was polyadenylated at its 3-end using poly(A) poly-
merase (Invitrogen) followed by first-strand cDNA synthe-
sis primed with oligo(dT) and PCR using an HMPV specific
reverse primer and a forward UAP primer supplied with the
kit. Then, RACE products were used as template for a
nested-PCR using an internal HMPV specific reverse primer
and the AUAP primer supplied with the kit to improve the
specificity of the reaction. Finally, the amplified cDNA
nested-PCR products were sequenced directly.
To map and sequence the 5 end of the HMPV genome,
virion RNA was processed by first-strand cDNA synthesis
using a primer specific to the downstream end of the HMPV
L gene, terminal transferase tailing, and PCR amplification
as specified by the 5 RACE System for Rapid Amplifica-
tion of cDNA 5 end Version 2.0 (Invitrogen) using the
AAP primer supplied with the kit. Then, the amplified
cDNA RACE products were used as template for a nested-
PCR using an internal HMPV specific primer and the
AUAP primer supplied with the kit to improve the speci-
ficity of the reaction. Finally, the amplified cDNA nested-
PCR products were sequenced directly.
The 5 and 3 ends of the HMPV CAN97-83 genome
also were confirmed by genomic RNA ligation and RT-PCR
followed by sequencing. Briefly, vRNA isolated from su-
crose gradient purified virus was ligated in presence of 10 U
of T4 RNA ligase (Epicentre) for 3 h at 25°C and 3 h at
37°C. A cDNA corresponding to the junction of the ligated
ends was synthesized and amplified by RT-PCR using
HMPV specific primers from the upstream end of the N
gene and downstream end of the L gene. The RT-PCR
products were used as template for a nested-PCR using
additional HMPV primers that hybridize closer to the re-
spective termini to improve the specificity of the reaction.
Finally, the nested-PCR products were cloned into a blunt
vector (pSTBlue-1; Novagen) and 20 clones were se-
quenced, thereby independently confirming the length, con-
tent, and sequence of the two ends of the HMPV genome.
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